WTO Cannot Continue as Barrier to COVID-19 Medicines
By Joseph E. Stiglitz and Lori Wallach
It’s unimaginable that more than two years into the pandemic with more than 15 million people killed, World Trade Organization (WTO) countries are still stuck debating whether WTO intellectual property barriers should be waived for COVID-19 vaccines, treatments and tests.
Actually, that’s not quite correct: The needed waiver has been scotched thanks to a few wealthy countries doing Big Pharma’s bidding.